NEUWAY Pharma

NEUWAY Pharma

NEUWAY Pharma

NEUWAY focuses on the preclinical and clinical development of innovative therapeutics for treatment of severe orphan brain diseases based on its proprietary CNS Drug Delivery Platform.
Founded
2014
Raised
$7M
Follow us
Alexa global traffic share
Latest funding
$3,683,291
Venture capital (Series A) - 2014
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when NEUWAY Pharma makes some noise.